We are live on !
Find out more
XTL Biopharmaceuticals
XTLB
XTLB
1.64
USD
-0.02
1.2%
At close
Updated
Nov 12, 4:00 PM EST
Pre-market
After hours
1 day
-1.2%
5 days
-1.8%
1 month
-14.58%
3 months
-39.03%
6 months
-37.16%
Year to date
-31.67%
1 year
-57.73%
5 years
-88.61%
10 years
-88.13%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
1
Noked Israel
Ramat Hasharon,
Israel
| $227K | – | – | – |
|
| 2 |
2
RhumbLine Advisers
Boston,
Massachusetts
| $20K | +$7.65K | +1,576 | +58% |
|
| 3 |
3
Morgan Stanley
New York
| $12.6K | -$2.72K | -560 | -17% |
|
| 4 |
4
UBS Group
Zurich,
Switzerland
| $1.52K | +$1.62K | +334 | New |
|
| 5 |
5
Citadel Advisors
Miami,
Florida
| – | -$31.3K | -6,303 | Closed |
|